Financial Daily from THE HINDU group of publications Monday, Mar 22, 2004 |
||
|
|
||
|
Markets
-
Stock Markets Info-Tech - Stocks Columns - ADR Watch IT counters end firm K.S. Badri Narayanan
UNABATED selling pressure pushed equities down at the US and the Indian bourses. Except for the infotech counters, most of the Indian ADRs finished last week on a weak note. Hopes that Indian infotech majors, which are scheduled to announce their fourth-quarter and full-year results next month, will perform strongly seemed to have induced some buying interest into these stocks. Besides, for Infosys, the `buy' recommendations from research firms Janney Montgomery Scott LLC and FTN MidWest Research fuelled positive sentiment. A couple of tie-up announcements by Satyam Computer seemed to have acted as a catalyst for the counter. Satyam announced the signing up of a regional partnership with Actuate Corporation, an ERP firm, under the Actuate Asia-Pacific Partner Program. It also announced a tie-up with LeftBrain Inc, a provider of integrated supplier relationship management. Following these, Infosys closed firm at $82.82 compared to the previous week's close of $79 and Satyam at $20.39 ($19.75). Wipro finished marginally up at $40.95 ($40.45). Reports that Dr Reddy's, whose diabetes drug licensed to Denmark's Novo-Nordisk A/S is expected to enter the third and most-advanced stage of human trials, soon failed to reinvigorate the counter. Dr Reddy's closed last week at $23.76 ($24.10). VSNL, which announced the acquisition of assets of DishnetDSL for Rs 270 crore, also ended the week on negative note at $8.36 ($8.70). On the premium/discount front, there was not much deviation.
More Stories on : Stock Markets | Stocks | ADR Watch
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2004, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|